← All trials
NCT03602053
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2018
- Primary completion
- Oct 31, 2019
- Completion date
- Mar 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 450
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centre for Infectious Disease Research in Zambia (CIDRZ)Lead sponsor
- PATHStudy director
- Centre for Infectious Disease Research in Zambia (CIDRZ)Reponsible party - principal investigator
- PATHCollaborator
- University of CincinnatiCollaborator
- Bharat Biotech International LimitedCollaborator
- Christian Medical College, Vellore, IndiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.